Alto Neuroscience ANRO Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's accrued liabilities, current?
- Alto Neuroscience (ANRO) reported accrued liabilities, current of $7.61M in Q1 2026.
- How has Alto Neuroscience's accrued liabilities, current changed year-over-year?
- Alto Neuroscience's accrued liabilities, current increased by 29.6% year-over-year, from $5.87M to $7.61M.
- What is the long-term trend for Alto Neuroscience's accrued liabilities, current?
- Over 2 years (2023 to 2025), Alto Neuroscience's accrued liabilities, current has grown at a 39.8% compound annual growth rate (CAGR), from $4.54M to $8.86M.